Lexicon Pharmaceuticals, Inc. (LXRX)
1.54
+0.02
(+1.32%)
USD |
NASDAQ |
Oct 19, 16:00
1.54
0.00 (0.00%)
After-Hours: 17:23
Lexicon Pharmaceuticals Cash from Operations (Annual) : -67.85M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -67.85M |
| December 31, 2024 | -180.09M |
| December 31, 2023 | -161.90M |
| December 31, 2022 | -88.85M |
| December 31, 2021 | -87.02M |
| December 31, 2020 | -142.97M |
| December 31, 2019 | 113.81M |
| December 31, 2018 | -148.61M |
| December 31, 2017 | -185.39M |
| December 31, 2016 | -175.63M |
| December 31, 2015 | 184.78M |
| December 31, 2014 | -75.62M |
| December 31, 2013 | -91.08M |
| December 31, 2012 | -94.46M |
| December 31, 2011 | -87.94M |
| Date | Value |
|---|---|
| December 31, 2010 | -82.37M |
| December 31, 2009 | -89.02M |
| December 31, 2008 | -95.60M |
| December 31, 2007 | -74.32M |
| December 31, 2006 | -56.91M |
| December 31, 2005 | 23.44M |
| December 31, 2004 | -42.26M |
| December 31, 2003 | -7.716M |
| December 31, 2002 | -28.79M |
| December 31, 2001 | -17.99M |
| December 31, 2000 | -1.502M |
| December 31, 1999 | -9.615M |
| December 31, 1998 | -6.308M |
| December 31, 1997 | -0.6965M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Bristol Myers Squibb Co. | 14.16B |
| ANI Pharmaceuticals, Inc. | 185.22M |
| Corcept Therapeutics, Inc. | 142.00M |
| Veru, Inc. | -30.04M |
| Johnson & Johnson | 24.53B |